Work

Abstract P3-10-09: A Phase II trial of doxil, carboplatin and bevacizumab in metastatic triple negative breast cancer and molecular correlates of response

Year: 2015

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs14-p3-10-09

Authors: Kim M Hirshfield, Shou-En Lu, Serena Wong, Antoinette Tan, Laurie Kirstein, Thomas Kearney, Weichung Shih, Shridar Ganesan, Deborah L Toppmeyer

Institution: Rutgers Cancer Institute

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W409819159

Cites:

Cited by:

Related to: 10